Chrys Maoudis

Dynamic and results-oriented professional with a comprehensive background as a Research and Development Manager and Manager for CMC and Technology Transfer. Experienced in overseeing critical CMC and technology transfer activities within Aegros, including the development, scale-up, and transfer of pharmaceutical and biotechnological products while ensuring strict compliance with regulatory standards. Experienced in assuming pivotal roles, including Acting Head of R&D – Protein Chemistry, and adept at delivering on key performance indicators (KPIs) with a focus on efficiency and regulatory compliance. Skilled in managing high-stakes situations such as leading the war room for a successful TGA audit, showcasing leadership and organizational prowess. Recognized for driving strategic initiatives such as Project Genesys and enhancing collaboration with external partners to bolster research capabilities. Adept at steering key projects through product and process development stages, extending to Pilot Scale and Commercialization. Recognized for developing and implementing company-wide strategies for CMC and technology transfer to facilitate rapid commercialization and product development. Skilled in implementing procedures for product development globally, adhering to GMP standards and incorporating principles of QBD from research to commercialization phases. Seeking a challenging role as Head of Research and Development or Head of Product Development within the pharmaceutical, biotechnology, or medical devices industry to leverage this diverse skill set and drive innovation, growth, and regulatory compliance.

Chrysostomos C. Maoudis, Flyn Mckinnirey, Ewa M. Goldys, Graham Vesey. Characterisation of adipose-derived mesenchymal stem cell secretions under a range of pre-conditioning treatments in regard to immunomodulation, angiogenesis, and effectiveness against pain. Journal of Stem Cell Research and Therapy. (submitted)

Chrysostomos Constantine Maoudis, Flyn McKinnirey, Graham Vesey et al. Mesenchymal Stem Cell Secretome Ameliorates Hyperalgesia in a Post-operative Pain Model, 19 July 2021, PREPRINT (Version 1) available at Research Square [https://doi.org/10.21203/rs.3.rs-709385/v1]

Brian Saputro, Chrys Maoudis, Grace Crosland, Sarah Abuobeid, Nadia Rahi, Anouschka Akerman, Stuart Turville, Anthony Kelleher, Mark Bailey, Hari Nair & Stephen Mahler, Characterisation of anti-SARS-CoV-2 hyperimmune globulin produced by HaemaFrac® technology. BPN Conference 2023 (Poster)

Chrys Maoudis, Brian Saputro, Grace Crosland, Sarah Abuobeid, Nadia Rahi, Mark Bailey, Hari Nair & Stephen Mahler, Chrys Maoudis. BPN Conference 2023

Chrys Maoudis, Brian Saputro, Zeena Amini, Grace Crosland, Nadia Rahi, Stephen Mahler, John Foster, Hari Nair, Bioprocessing Innovation - Plasma Fractionation by Haemafrac® Technology BPN Conference 2022

COVID-19 Hyperimmune globulin (Aegros) for the prevention of hospitalisation in patients with immunocompromise: a protocol Australian Society for Infectious Disease (ASID) Conference (Poster)

Brian Saputro, Chrys Maoudis, Grace Crosland, Sarah Abuobeid, Nadia Rahi, Leon Rozen, Anouschka Akerman, Stuart Turville, Anthony Kelleher, Mark Bailey, Hari Nair & Stephen Mahler, Characterisation of anti-SARS-CoV-2 hyperimmune globulin produced by HaemaFrac® technology. Blood 2023 (Poster)